You just read:

AbbVie Receives FDA Orphan Drug Designation for Investigational Medicine Veliparib for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer

News provided by

AbbVie

04 Nov, 2016, 13:33 ET